Global Histone Deacetylase 1 Market Key Players 2017 – 4SC AG, Celgene Corp, and HitGen LTD
Overview
Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Histone deacetylase 1 is an enzyme encoded by the HDAC1 gene. The protein encoded by this gene belongs to the histone deacetylase family and is a component of the histone deacetylase complex. It also interacts with retinoblastoma tumor-suppressor protein and this complex is a key element in the control of cell proliferation and differentiation.
Together with metastasis-associated protein-2 MTA2, it deacetylates p53 and modulates its effect on cell growth and apoptosis. It plays an important role in transcriptional regulation, cell cycle progression and developmental events.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/2258204-histone-deacetylase-1-hdac1-or-ec-3-5-1-98-pipeline-review-h2-2017
Top Companies mentioned
4SC AG
Celgene Corp
HitGen LTD
IRBM Science Park SpA
Medivir AB
Histone Deacetylase 1 Industry Major Outlook
Pharmaceutical and Healthcare latest pipeline guide Histone Deacetylase 1 - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Histone Deacetylase 1 , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Histone Deacetylase 1 (Hepatopoietin A or Scatter Factor or HGF) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 1, 1, 5 and 2 respectively.
Histone Deacetylase 1 pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Histone Deacetylase 1 - Competitive Analysis
Key players are making innovative developments in Histone Deacetylase 1 industry. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector
Scope
The pipeline guide provides a snapshot of the global therapeutic landscape of Histone Deacetylase 1.
The pipeline guide reviews pipeline therapeutics for Histone Deacetylase 1 by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Histone Deacetylase 1 therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Histone Deacetylase 1 therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Histone Deacetylase 1.
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2258204-histone-deacetylase-1-hdac1-or-ec-3-5-1-98-pipeline-review-h2-2017
About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Posted by
Vivian Dsena
on Thursday February 22 2018, 5:48 AM EST.
All trademarks acknowledged.
Filed under Uncategorized.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
